|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Infinity Pharmaceuticals, Inc.
| | | Phone: | (781) 895-0600 | Fax: | (781) 895-0611 | Year Established: | 2001 | Ticker: | INFI | Exchange: | NASDAQ | Main Contact: | Lawrence Bloch, M.D., J.D., President | | Other Contacts: | Jeffery Kutok, M.D., Ph.D., CSO Seth Tasker, VP & General Counsel Adelene Perkins, CEO Sujay Kango, Executive VP & CCO Samuel Agresta, M.D., M.P.H., CMO
| | Company Description | Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging cancer pathways. Infinity's two most advanced programs in Hsp90 chaperone inhibition and Hedgehog signaling pathway inhibition are evidence of its innovative approach to oncology drug discovery and development. | |
|
|
|
|
|